Evidence map›Paper›PMID 10477313›Full record

ReviewMicrobiology and molecular biology reviews : MMBR1999

Fungal resistance to plant antibiotics as a mechanism of pathogenesis.

J P Morrissey, A E Osbourn

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Nicotine Degradation byMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Plants (Basel, Switzerland) · 2025
    Article
  7. Synergistic effects ofFrontiers in antibiotics · 2025
    Article
  8. Article
  9. Article
  10. Microorganisms · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Chemical Ecology of Plant Natural Products.Progress in the chemistry of organic natural products · 2024
    Review
  16. Article
  17. Investigation of Pomegranate (Veterinary sciences · 2023
    Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J P MorrisseySainsbury Laboratory, John Innes Centre, Norwich NR4 7UH, United Kingdom. john.morrissey@bbsrc.ac.uk
A E Osbourn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many plants produce low-molecular-weight compounds which inhibit the growth of phytopathogenic fungi in vitro. These compounds may be preformed inhibitors that are present constitutively in healthy plants (also known as phytoanticipins), or they may be synthesized in response to pathogen attack (phytoalexins). Successful pathogens must be able to circumvent or overcome these antifungal defenses, and this review focuses on the significance of fungal resistance to plant antibiotics as a mechanism of pathogenesis. There is increasing evidence that resistance of fungal pathogens to plant antibiotics can be important for pathogenicity, at least for some fungus-plant interactions. This evidence has emerged largely from studies of fungal degradative enzymes and also from experiments in which plants with altered levels of antifungal secondary metabolites were generated. Whereas the emphasis to date has been on degradative mechanisms of resistance of phytopathogenic fungi to antifungal secondary metabolites, in the future we are likely to see a rapid expansion in our knowledge of alternative mechanisms of resistance. These may include membrane efflux systems of the kind associated with multidrug resistance and innate resistance due to insensitivity of the target site. The manipulation of plant biosynthetic pathways to give altered antibiotic profiles will also be valuable in telling us more about the significance of antifungal secondary metabolites for plant defense and clearly has great potential for enhancing disease resistance for commercial purposes.

Indexed as

Anti-Infective AgentsDrug Resistance, MicrobialFungiPhytoalexinsPlant ExtractsPlantsSesquiterpenesTerpenesAnti-Infective AgentsPhytoalexinsPlant ExtractsSesquiterpenesTerpenes

Identifiers

PMID10477313
PMCPMC103751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.